	Manage CVD Risk in Patients with Reduced eGFR

Manage CVD Risk in Patients with Reduced eGFR

この情報はストアのものより古い可能性がございます。
	価格	無料	ダウンロード
	ｼﾞｬﾝﾙ	メディカル
	サイズ	3.4MB
	開発者	National Kidney Foundation
	順位	ｼﾞｬﾝﾙ別： --- 総合： ---
	ﾘﾘｰｽ日	2011-04-08 04:22:02
	評価	評価が取得できませんでした。
	互換性	iOS 以降が必要です。 iPhone、iPad および iPod touch 対応。

Helps medical professionals reduce risks associated with major traditional and non-traditional risk factors for cardiovascular disease (CVD). Includes an interactive algorithm to quickly identify high-risk patients and apply evidence-based strategies to assess and treat. Content is adapted from KDOQI evidence-based clinical practice guidelines and recommendations from the National Kidney Foundation.

Features:
Designed for rapid, convenient, point-of-care intervention whenever and wherever you need it. With a few quick taps, you will:
•Help reduce risks associated with major traditional and non-traditional risk factors for cardiovascular disease (CVD)
•Quickly identify high-risk patients
•Apply evidence-based CVD risk reduction strategies to assess and treat using an inter-professional team approach
•Apply best practices related to professional and patient roles in medication adherence

Simple, practical information organized by:
•Risk Factors
•Facts
•Treatment
•About Chronic Kidney Disease -- a Major CVD Risk Factor
•Information: References; Abbreviations; About NKF

The Facts
•Kidney disease is common, harmful, and treatable.
•26 million Americans have kidney disease – but most do not know they have it. Millions more are at increased risk.
•High risk groups include those with diabetes, hypertension, and a family history of kidney disease. African Americans, Hispanics, Asian or Pacific Islanders, Native Americans and seniors are also at increased risk.
•Early detection can slow the progression of kidney disease.
•Once kidneys fail, patients need dialysis or a transplant to survive.

What is the National Kidney Foundation?
The National Kidney Foundation (NKF), a major voluntary nonprofit health organization, is dedicated to preventing kidney and urinary tract disease, improving the health and well-being of individuals and families affected by these diseases and increasing the availability of all organs for transplantation.

NKF’s Kidney Disease Outcomes Quality Initiative (KDOQI)® has developed and disseminated 12 clinical practice guidelines for the care of people at all stages of CKD. The NKF also manages an international organization, KDIGO, which is dedicated to improving outcomes for CKD patients worldwide. Thousands of health care professionals join the NKF as members and attend the annual NKF Spring Clinical Meetings. The NKF also publishes four respected, peer-reviewed scientific journals.

30 East 33rd Street
New York, NY 10016
www.kidney.org
800-622-9010

This program is made possible by a grant from Pfizer, Inc.

更新履歴
Typographical correction.